carnitine has been researched along with carboplatin in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abd-Allah, AR; Al-Majed, AA; Al-Shabana, OA; Al-Yahya, AA; Fouda, SI | 1 |
Bisonni, R; Calvani, M; D'Iddio, S; Graziano, F; Lippe, P; Mancinelli, A | 1 |
Arafa, HM | 1 |
Haschke, M; Herrmann, R; Krähenbühl, S; Lüde, S; Novakova, K; Todesco, L; Vitins, T | 1 |
Chang, CC; Chou, HC; Chou, Y; Juan, SH; Sue, YM; Yang, NJ | 1 |
1 trial(s) available for carnitine and carboplatin
Article | Year |
---|---|
Urinary excretion of L-carnitine and its short-chain acetyl-L-carnitine in patients undergoing carboplatin treatment.
Topics: Acetylcarnitine; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Carnitine; Chromatography, High Pressure Liquid; Creatinine; Docetaxel; Female; Glucose; Humans; Infusions, Intravenous; Kidney; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms; Paclitaxel; Phosphates; Taxoids; Urea; Vinblastine; Vinorelbine | 2007 |
4 other study(ies) available for carnitine and carboplatin
Article | Year |
---|---|
L-Carnitine halts apoptosis and myelosuppression induced by carboplatin in rat bone marrow cell cultures (BMC).
Topics: Animals; Antineoplastic Agents; Apoptosis; Bone Marrow Cells; Carboplatin; Carnitine; Cell Survival; Cells, Cultured; Colony-Forming Units Assay; Glutathione; Granulocytes; Macrophages; Male; Malondialdehyde; Rats; Rats, Wistar | 2005 |
Carnitine deficiency aggravates carboplatin nephropathy through deterioration of energy status, oxidant/anti-oxidant balance, and inflammatory endocoids.
Topics: Adenosine Triphosphate; Animals; Antioxidants; Blood Urea Nitrogen; Carboplatin; Carnitine; Creatinine; Inflammation; Kidney; Kidney Diseases; Male; Nitric Oxide; Oxidants; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha | 2008 |
Urinary excretion of carnitine as a marker of proximal tubular damage associated with platin-based antineoplastic drugs.
Topics: Adult; Aged; Antineoplastic Agents; Biomarkers; Carboplatin; Carnitine; Cells, Cultured; Cisplatin; Female; Humans; Kidney Diseases; Kidney Tubules, Proximal; Male; Middle Aged; Organic Cation Transport Proteins; Organoplatinum Compounds; Oxaliplatin; Solute Carrier Family 22 Member 5 | 2010 |
L-carnitine protects against carboplatin-mediated renal injury: AMPK- and PPARα-dependent inactivation of NFAT3.
Topics: Acute Kidney Injury; AMP-Activated Protein Kinases; Animals; Apoptosis; Carboplatin; Carnitine; Cyclooxygenase 2; Gene Expression Regulation; Gene Knockdown Techniques; Humans; Inflammation; Kidney; Mice; NFATC Transcription Factors; PPAR alpha; Protective Agents; Rats; Reactive Oxygen Species; Signal Transduction | 2014 |